{"name":"Ascidian Therapeutics, Inc","slug":"ascidian-therapeutics-inc","ticker":"","exchange":"","domain":"ascidian.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ACDN-01","genericName":"ACDN-01","slug":"acdn-01","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ACDN-01","genericName":"ACDN-01","slug":"acdn-01","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWDVVT0I3X1p5NmhLaFpnNkMyMzEtX3pYb3RQd25VamMzbnlwVWFyTFFvVk9NaHhrY0tDSzFzQy1xaGpJdmxmdWJ6TW9EUjdPZFNWODNremFrZjUxX2NxZWpFMVIza2JVUFdvWXExMTV4MXBHY2REeUN4bmtRSmhYSy0yWVcybHZUaWNESGFNc042LWhHcTd4N3E1RFZnOFFWU0xIT1Q5SFMwTGhNRk9tay00MlRzcjdHLUFBamJNSXZmTzV2V1RxekhqU3poSl9F?oc=5","date":"2026-02-25","type":"regulatory","source":"BioCentury","summary":"Rare disease spotlight: Stargardt’s first approval in sight as next-gen aims to restore vision - BioCentury","headline":"Rare disease spotlight: Stargardt’s first approval in sight as next-gen aims to restore vision","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQOWFraXV1bGdhNGs3SmFhU3VmaEtPemVsY1NuNWozc0pPcmoxcW9UZmkxX0JMdnl5czZla09jVlB1UHVma0hjRnE1Zkpfd3MtVEloa0tXcDFxTmlUZFpLcHI3TmlrRjUwdGdyWjdFV2hOZXExOGM3TjhuRHhuTXQyVktiRGF0Ni1vVnFZaEJLVVJyeWRkSUJncVV6TlR1N1RuT3lMaElOb1pvaGszSHpKQWxfVXJ2MGlOS1hyS3pmSW9SdVczbWhhQjN6eUdDQTMwMklhbWpmQ3FGUFhZSW51aUJnakZyYkdOV0FQdmppaGhLR2VORHExWW5xV0ZMOW95SGFxOGpraE9XRDU0SGRGekVkazI?oc=5","date":"2026-01-07","type":"deal","source":"businesswire.com","summary":"Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease - businesswire.com","headline":"Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPR1N0MDkzWTRLS2lTeXhFUXYyUm5NQWpVZUZRbjVoOUVUaG9NenhVOXdpSTdLaDVfek9nZmFWM3Yya29EWWptUzNaRkF3RXlqTUwyZ0RmbTdmSHZoYmZONEQwZmNDdzAzV21aVkR2UG11OGhqUlNRMmhFZUF3RkIxRUVIZENIaHhaZ25Xbi1VOWo4ejBhZUMwRERGMVRYeVNiM3VoYkhxQ0tXbXN5eGZhZEc0cDdtdm9ycFpVcUhJWQ?oc=5","date":"2026-01-07","type":"deal","source":"Contract Pharma","summary":"Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment - Contract Pharma","headline":"Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWTFjeFh5Vk5fb0RSNG14Q3YydHBIc050Y1BwRjgtNEREaS1mRXljblphdWhpbTVwQXV6WmdkelpmSjh6QjFSN01uN1VoeE82bGtLbS1Fay1vYlZSYl9ZMjBPSVQxU3RvbFR6ZUVLRmFNQ1IyMEg3azlLcjNYVzUtb01HdVBaQi1keTZ2RmtZZjdzcExXZkpRT0M0OXFTYkpBVEJ4UlN4Z0VZNVEwSHZjSlZaSDJzTXg2ZUxlaEduWQ?oc=5","date":"2025-12-10","type":"deal","source":"Fierce Biotech","summary":"Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs - Fierce Biotech","headline":"Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1WQWVKSGRjX1A1eG1yeklaNEpnaU9wamFFa1h0YmlRMEV6YkpUT2FMNkVIWW1ieF9OcndpZGFLbDJyWERoSmZJeks3VC1nNGlmOU5IRFRBVTZiN2tMREVEbXp1eDhrM1E5MHdIZV9IQ0g?oc=5","date":"2025-11-11","type":"pipeline","source":"Labiotech.eu","summary":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025 - Labiotech.eu","headline":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOWnFwcEFyaWluNXNacFJfeWQ2NVdsUjEzRG1YeS1TWDUzQ01vYzBtN1lSOHNZMGRjREktdEdBOWV6U2l6QUwtLTI0MVFpekxyTFM0NDZVSkJmN0RKSlZ5bWRDMnNCeWJjNGtER3hJaUE1YjdyVExDeEdEamd2Mi1LcncyTDBHdl9tdl9YWlRXSEh0ZERXVzRTMEkzbkY3V29CMmFVdW1uV2p3NHNkVmNXdE9aUDU1VGV4ZGVXeVpFVXVJY1dydjIxclA3MkFkeGlvem9SUjB0dlRFZlBlWXJ5NDFCalBpSmk5VkhpUl9fT3pHSUdGZGU1YTRhSzZwWnNMQUlCWkZLSXJGbE1mX1NZ?oc=5","date":"2024-11-19","type":"pipeline","source":"GlobeNewswire","summary":"Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight - GlobeNewswire","headline":"Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNVEpaWXFNSHhONVJYc3NYZXJxZUt6TWVGa2FyLTExRGh4TlVtSnRLX2pyNi1ZYk5BUGg1TnRaMkc0MlZUaldjaTVSYjBQa2ZvSk9fQ2FuQUtYSERPMUltdUloRHBNa2toRmJEMUdHRVdKUWNFcWhMZE9IRGpxYXc4S1p3VXB6cXZfUXRKTmlocG5jQQ?oc=5","date":"2024-08-05","type":"pipeline","source":"Fierce Biotech","summary":"Introducing Fierce Biotech's 2024 Fierce 15 - Fierce Biotech","headline":"Introducing Fierce Biotech's 2024 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOT0RlVExmTUpuUjZHMHlpZ1AwaVMxb0kyYlpjM0dnRUtGbnNHV1pYZTN1V0dxdUVCc3JoSkozWkZzeVBLNWxUSHluVUEwSHZOTUNMdVVTeUJ4LXQ4N1lXUllrMElQQ242UXNuSktrUFk1UVcyd2pPM0p5aDl3TmNrRjlyOEJtUjY2Qm85Y3J1QmJoWnE4V1lzMVYtWU1LS3B3aVNJUllGc2MwX3ZpUEk3Uzg0YXhDM0JQbUFLVHJjS0hISXNLUTFUd0FxM0t1cS1ua2c?oc=5","date":"2024-06-18","type":"deal","source":"Reuters","summary":"Roche partners with Ascidian Therapeutics to develop gene therapies - Reuters","headline":"Roche partners with Ascidian Therapeutics to develop gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQTlY3UW1jUkZKQ0xkczU5cXJERE1odjJGWEhvS2VHUXVQSlkwSDhDTzFxallOX2g1ay13S1d1Mi1SQ285TVdPRHlNazRPbmIydEtHUVNRUERqcUJJb2dpN2lRc3ZjbV80blBuYWZQS2g5TnlXd0tqY3VQaXhmc2IzcGh1UVNWYmw0d19Ycg?oc=5","date":"2024-06-18","type":"deal","source":"BioPharma Dive","summary":"Roche partners with RNA editing biotech Ascidian - BioPharma Dive","headline":"Roche partners with RNA editing biotech Ascidian","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxQS0JhTEdTV3h1X0Fyb04zQS1rTlZ2MzVJLXQwZzlVWUVCOGhlWV9nZ1pBNDVFTVNMZzJIeUJINWo0UkJqWWxJbEwwWDFKaVZnVEJyZldRc0kwNnNSa1FSWXhSV2lqUTlTdkMxdXVDLWx0VGQzRzhOc0tOTmlUMzJiYXFUVV9zUnF0TGphc3JjVG43Tjh3V1hDbFo5cWZHdkl6YXczUTJlWDZUMEItRm92bWdNVWZoenZBVWdQYk9ZRW5UcGhSaEhGM2YyTkc0V3JEMl9vbW5LUlZlNXEzdUxmTlpRdDZhQXBmSTZrUVZMczlsOTZFVGI2UHdhdUtoSG5LM2VwamdIdTFOVzM5RGd2TGZXRzAzVDN4dHJqVWE3dHFzRHpjZFFreUtpaG8?oc=5","date":"2024-06-18","type":"deal","source":"prnewswire.com","summary":"Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Targeting Neurological Diseases - prnewswire.com","headline":"Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Tar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNaTFDNnNTdTdaXzJXdjJ5bEx1ZlNjYnd6dXNpVDVYekhhTmFlZDJ3dFY1aDNLRHVhTGdBQ1kycGtFSnFHUTNhVHNUdUstQXZENHF0cF9jTmtiRVZFdnpCT1NVVWtyMVAzSVhzS0pCOHhMcW5xRTlaaTE0Nzh3TkE3aUEta01wQ04zNHp6UlRqV295aHlCT25BRlV3d0RYZkRGMEo1N1I0cTkxTldfN3pUYVBrQXRRbDVmZng0UnM0dy1mdzd2MUJzd0xyYWpFM0QxVmNCNWxZVDlmUGtHUkxnZUdGaHBpQUU0UEtVVEJVb0ZieWs4RU1rc0pNLTR2dVRlS2s3WUFDQmE?oc=5","date":"2023-04-11","type":"pipeline","source":"prnewswire.com","summary":"Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic - prnewswire.com","headline":"Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clini","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}